Applied Therapeutics, Inc.
Price Action
Technical Summary
CONSOLIDATINGApplied Therapeutics, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 6), showing significant lag compared to the market leaders. Earnings growth of 73% provides fundamental context to the price action. Investors should exercise caution due to high volatility (164% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.10 | +2.49% | ABOVE |
| 50 SMA | $0.14 | -26.11% | BELOW |
| 100 SMA | $0.50 | -79.25% | BELOW |
| 150 SMA | $0.48 | -78.71% | BELOW |
| 200 SMA | $0.46 | -77.62% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is APLT in an uptrend right now?
APLT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is APLT overbought or oversold?
APLT's RSI (14) is 36. The stock is in neutral territory, neither overbought nor oversold.
Is APLT outperforming the market?
APLT has a Relative Strength (RS) Rating of 6 out of 99. APLT is currently lagging the broader market.
Where is APLT in its 52-week range?
APLT is trading at $0.10, which is 7% of its 52-week high ($1.50) and 1% above its 52-week low ($0.09).
How volatile is APLT?
APLT has a Beta of 3.25 and 52-week volatility of 164%. It's more volatile than the S&P 500 - expect bigger swings.